Skip to main content

Advertisement

Log in

A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Motor excitability is increased in both hemispheres in stroke patients during motor recovery. Pharmacologically controlled changes of cortical excitability might be beneficial for synaptic plasticity and therefore facilitate functional recovery after a brain lesion. In particular, it has been suggested that antidepressant drugs can modulate motor excitability. Several recent reports suggest the possibility of monitoring pharmacological effects on brain excitability through transcranial magnetic stimulation (TMS). The aim of this study was to investigate motor area excitability in patients with stroke after oral administration of citalopram. We conducted a prospective randomised placebo controlled study. Twenty patients with unilateral stroke were included in the study: ten patients treated by antidepressive drug and ten patients with placebo. A selective serotonergic drug (citalopram) or a placebo was administered using a mean dosage of 10 mg/day in combination with physiotherapy. Motor cortex excitability was studied by single and paired transcranial magnetic stimulation. TMS recording was tested before (T1) and 1 month after (T2) beginning drug treatment. Patients treated by the serotonergic drug, compared to patients that received a placebo, showed a significant improvement in neurological status as measured by NIHSS and a decrease of motor excitability over the unaffected hemisphere, while no differences were observed over the affected hemisphere. Our findings suggest that treatment with serotonergic drugs can bring about a significant decrease of the motor cortex excitability in stroke patients with effects on both the affected and unaffected hemispheres associated with a better motor recovery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Andersen G, Vestergaard K, Lauritzen L (1994) Effective treatment of post-stroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 25:1099–1104

    PubMed  CAS  Google Scholar 

  2. Berthier ML, Hinojosa J, Martin MC, Fernandez I (2003) Open-label study of donezepil in chronic post-stroke aplasia. Neurology 60:1218–1219

    Article  PubMed  Google Scholar 

  3. Berthier ML, Pujol J, Gironell A, Kulisevsky J, Deus J, Hinojosa J (2003) Beneficial effect of donezepil on sensorimotor function after stroke. Am J Phys Med Rehabil 82:725–729

    Article  PubMed  Google Scholar 

  4. Bobath B (1970) Adult hemiplegia: evaluation and treatment, 2nd edn. William Heinemann Medical Books, London

    Google Scholar 

  5. Chemerinski E, Robinson RG, Kosier JT (2001) Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke 32:113–117

    PubMed  CAS  Google Scholar 

  6. Chollet F, DiPiero V, Wise RJS, Brooks DJ, Dolan RJ, Frackowiak RSJ (1991) The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann Neurol 26:63–71

    Article  Google Scholar 

  7. Cohen LG, Ziemann U, Chen R, Classen J, Hallett M, Gerloff C, Butefisch C (1998) Studies of neuroplasticity with transcranial magnetic stimulation. J Clin Neurophysiol 15:305–324 (review)

    Article  PubMed  CAS  Google Scholar 

  8. Cramer SC, Nelles G, Benson RR, Kaplan JD, Parker RA, Kwong KK et al (1997) A fMRI study of subjects recovered from hemiparetic stroke. Stroke 28:2518–2527

    PubMed  CAS  Google Scholar 

  9. Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M (1996) Effects of fluoxetine and maptroline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27:1211–1214

    PubMed  CAS  Google Scholar 

  10. Gainotti G, Antonucci G, Marra C, Paolucci S (2001) Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry 71:258–261

    Article  PubMed  CAS  Google Scholar 

  11. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:58–62

    Google Scholar 

  12. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A et al (1993) Corticocortical inhibition in human motor cortex. J Physiol 471:501–519

    PubMed  CAS  Google Scholar 

  13. Liepert J, Storch P, Fritsch A, Weiller C (2000) Motor cortex disinhibition in acute stroke. Clin Neurophysiol 111:671–676

    Article  PubMed  CAS  Google Scholar 

  14. Lindmark B, Hamrin E (1988) Evaluation of functional capacity after stroke as a basis for active intervention. Presentation of a modified chart for motor capacity assessment and its reliability. Scand J Rehabil Med 3:103–109

    Google Scholar 

  15. Lyden P, Brott T, Tilley B, Welch KMA, Maascha EJ, Ninds TPA (1994) Stroke study group improved reliability of the NIH stroke scale using video training. NINDS TPA Stroke Study Group. Stroke 25:2220–2226

    PubMed  CAS  Google Scholar 

  16. Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J 14:61–85

    PubMed  CAS  Google Scholar 

  17. Manganotti P, Bongiovanni LG, Zanette G, Fiaschi A (1999) Cortical excitability in patients after loading doses of lamotrigine: a brain magnetic stimulation study. Epilepsia 40:316–321

    Article  PubMed  CAS  Google Scholar 

  18. Manganotti P, Bortolomasi M, Zanette G, Pawelzik T, Giacopuzzi M, Fiaschi A (2001) Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation. J Neurol Sci 184:27–32

    Article  PubMed  CAS  Google Scholar 

  19. Manganotti P, Patuzzo S, Cortese F, Palermo A, Smania N, Fiaschi A (2002) Motor disinhibition in affected and unaffected hemisphere in the early period of recovery after stroke. Clin Neurophysiol 113:936–943

    Article  PubMed  CAS  Google Scholar 

  20. Manganotti P, Acler M, Zanette GP, Smania N, Fiaschi A (2008) Motor cortical disinhibition during early and late recovery after stroke. Neurorehabil Neural Repair 22(4):396–403

    PubMed  CAS  Google Scholar 

  21. Martinsson L, Wahlgren NG, Hardemark HG (2003) Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev (3):CD002090

  22. Mittman T, Luhmann HJ, Schmidt-Kastner R, Eysel UT, Weigel H, Heinemann U (1994) Lesion induced transient suppression of inhibitory function in rat neocortex in vitro. Neuroscience 60:891–906

    Article  Google Scholar 

  23. Paolucci S, Antonucci G, Grasso MG, Morelli D, Troisi E, Coiro S, Ermani M (2001) Post-stroke depression, antidepressant treatment and rehabilitation results: a case–control study. Cerebrovasc Dis 12:264–271

    Article  PubMed  CAS  Google Scholar 

  24. Pariente J, Loubinoux I, Carel C, Albucher JF, Leger A, Manelfe C (2001) Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 55:454–456

    Google Scholar 

  25. Robol E, Fiaschi A, Manganotti P (2004) Effects of citalopram on the excitability of the human motor cortex: a paired magnetic stimulation study. J Neurol Sci 221:41–46

    Article  PubMed  CAS  Google Scholar 

  26. Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ et al (1994) Noninvasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91:79–92

    Article  PubMed  CAS  Google Scholar 

  27. Salkind MR (1969) Beck depression inventory in general practice. J R Coll Gen Pract 18:267–271

    PubMed  CAS  Google Scholar 

  28. Schiene K, Bruehl C, Zilles K, Qu M, Hagemann G, Kraemer M, Witte OW (1996) Neuronal hyperexcitability and reduction of GABA receptor expression in the surround of cerebral photothrombosis. J Cereb Blood Flow Metab 16:906–914

    Article  PubMed  CAS  Google Scholar 

  29. Stroemer RP, Kent TA, Hulsebosch CE (1998) Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with d-amphetamine therapy after neocortical infarction in rats. Stroke 29:2381–2393

    PubMed  CAS  Google Scholar 

  30. Talelli P, Greenwood RJ, Rothwwell JC (2006) Arm function after stroke: Neurophysiological correlates and recovery mechanism assessed by transcranial magnetic stimulation. Clin Neurophysiol 117:1641–1659 (review)

    Article  PubMed  CAS  Google Scholar 

  31. Tombari D, Ricciardi MC, Bonaffini N, Pasquini M, Cecconi M, DiPiero V, Lenzi GL (2006) Functional MRI, drugs, and poststroke recovery. Clin Exp Hypertens 28:301–307

    Article  PubMed  CAS  Google Scholar 

  32. Ward NS, Brown MM, Thompson AJ, Frackowiak RSJ (2003) Neural correlates of outcome after stroke: a cross-sectional fMRI study. Brain 126:1430–1448

    Article  PubMed  CAS  Google Scholar 

  33. Ward NS, Brown MM, Thompson AJ, Frackowiak RSJ (2004) The influence of time after stroke on brain activations during a motor task. Ann Neurol 6:829–834

    Article  Google Scholar 

  34. Werhahn KJ, Forderreuther S, Straube A (1998) Effects of the serotonin1B/1D receptor agonist zolmitriptan on motor cortical excitability in humans. Neurology 51:896–898

    PubMed  CAS  Google Scholar 

  35. Ziemann U, Rothwell JC, Ridding MC (1996) Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol 496:873–881

    PubMed  CAS  Google Scholar 

  36. Ziemann U (2004) TMS and drugs. Clin Neurophysiol 115:1717–1729 (review)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Manganotti.

Additional information

M. Acler and P. Manganotti equally participated to the work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Acler, M., Robol, E., Fiaschi, A. et al. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol 256, 1152–1158 (2009). https://doi.org/10.1007/s00415-009-5093-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-5093-7

Keywords

Navigation